MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location,and clinical correlation

Citation
R. Bakshi et al., MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location,and clinical correlation, NEUROREPORT, 11(1), 2000, pp. 15-21
Citations number
24
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROREPORT
ISSN journal
09594965 → ACNP
Volume
11
Issue
1
Year of publication
2000
Pages
15 - 21
Database
ISI
SICI code
0959-4965(20000117)11:1<15:MTS(TI>2.0.ZU;2-P
Abstract
Abnormal iron deposition occurs in the brains of patients with multiple scl erosis (MS) and may cause MRI T2 shortening ('black T2'; BT2). The frequenc y, distribution and clinical significance of BT2 in MS is unknown. Analysis of brain MRI scans of 114 MS patients showed BT2 in thalamus (n = 65; 57%) , putamen (n = 48; 42%), caudate (n = 27; 24%) and Rolandic cortex (n = 9; 8%). BT2 was significantly related to longer disease duration and advancing neurological disability. Wheelchair-bound patients had worse BT2 in thalam us (p < 0.05), putamen (p < 0.001) and Rolandic cortex (p < 0.05). Patients with secondary progressive disease (n = 34) had worse BT2 in thalamus, put amen and caudate (all p < 0.05) than those with relapsing-remitting disease (n = 80). BT2 is proposed as a clinically relevant finding relating to neu ronal degeneration in MS. NeuroReport 11:15-21 (C) 2000 Lippincott Williams & Wilkins.